Phase XIII, group 2 - 01.07.2018 - 30.06.2021

Ca.-No 182

Macrophage-assisted DNA repair in the context of cutaneous papillomavirus/UV-induced skin carcinogenesis

Israeli Partner: J. Rachmilewitz, Hadassah Medical Center
German Partner: Frank Rösl, DKFZ

Ca.-No 183

Working principles of the Hsp70 chaperone system in cancer biology

Israeli Partner: Rina Rosenzweig, Weizmann Instiute
German Partner: Bernd Bukau, DKFZ

Ca.-No 184

Enhancing the efficacy of oncolytic viruses against prostate cancer through combination therapy

Israeli Partner: Eran Bacharach, Tel Aviv University
German Partner: Antonio Marchini, DKFZ

Publications

Ca.-No 185

Synthetic lethal targeting of acute myeloid leukemia driven by GATA2 haploinsufficiency

Israeli Partner: Shai Izraeli, Sheba Medical Center
German Partner: Stefan Fröhling and Stefan Gröschel, DKFZ

Publications

No publications available.

Ca.-No 186

ADAR1 involvement in NK activity against cancer

Israeli Partner: Ofer Mandelboim, Hebrew University
German Partner: Nina Papavasiliou, DKFZ

Ca.-No 187

Tumor microenvironment-driven reprogramming of luminal-A tumors towards a metastatic phenotype: Molecular determinants, epigenetic plasticity and clinical implications

Israeli Partner: Adit Ben-Baruch, Tel Aviv University
German Partner: Stefan Wiemann and Cindy Körner, DKFZ

Form

Form data is loaded ...